TSRPX
Price
$23.20
Change
-$0.14 (-0.60%)
Updated
Jul 31 closing price
Net Assets
4.06B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

TSRPX vs VSCIX

TSRPX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
TSRPX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSRPX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. TSRPX (4.06B). VSCIX pays higher dividends than TSRPX: VSCIX (1.23) vs TSRPX (0.70). TSRPX was incepted earlier than VSCIX: TSRPX (17 years) vs VSCIX (29 years). TSRPX (0.55) is less costly to investors than VSCIX (0.03). TSRPX is a more actively managed with annual turnover of: 76.00 vs. VSCIX (17.00). TSRPX has a lower initial minimum investment than VSCIX: TSRPX (0) vs VSCIX (5000000). TSRPX annual gain was more profitable for investors over the last year : 27.31 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. TSRPX (8.65).
TSRPXVSCIXTSRPX / VSCIX
Total Expense Ratio0.550.031,833%
Annual Report Gross Expense Ratio0.550.031,833%
Fund Existence17 years29 years-
Gain YTD19.28014.591132%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.06B189B2%
Annual Yield % from dividends0.701.2357%
Returns for 1 year27.3122.58121%
Returns for 3 years37.9343.4487%
Returns for 5 years8.6535.1325%
Returns for 10 years47.27156.0730%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C